Neuromelanin changes in first episode psychosis with substance abuse

被引:4
作者
Jalles, Constanca [1 ]
Chendo, Ines [2 ,3 ]
Levy, Pedro [3 ]
Reimao, Sofia [2 ,4 ]
机构
[1] Univ Lisbon, Fac Med, Lisbon, Portugal
[2] Inst Med Mol, Clin Pharmachol Unit, Lisbon, Portugal
[3] Hosp Santa Maria, Dept Psychiat, Dept Neurosci, Lisbon, Portugal
[4] Univ Lisbon, Imaging Univ Clin, Fac Med, Lisbon, Portugal
关键词
SCHIZOPHRENIA;
D O I
10.1016/j.schres.2020.03.034
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:283 / 284
页数:2
相关论文
共 10 条
  • [1] Neuroimaging of the dopamine/reward system in adolescent drug use
    Ernst, Monique
    Luciana, Monica
    [J]. CNS SPECTRUMS, 2015, 20 (04) : 427 - 441
  • [2] Neurocircuitry of drug reward
    Ikemoto, Satoshi
    Bonci, Antonello
    [J]. NEUROPHARMACOLOGY, 2014, 76 : 329 - 341
  • [3] Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia
    Rice, Matthew W.
    Roberts, Rosalinda C.
    Melendez-Ferro, Miguel
    Perez-Costas, Emma
    [J]. BRAIN STRUCTURE & FUNCTION, 2016, 221 (01) : 185 - 201
  • [4] A neurophysiological and neuropsychological consideration of mindful movement: clinical and research implications
    Russell, Tamara Anne
    Arcuri, Silvia Maria
    [J]. FRONTIERS IN HUMAN NEUROSCIENCE, 2015, 9
  • [5] Visual discrimination among patients with depression and schizophrenia and healthy individuals using semiquantitative color-coded fast spin-echo T1-weighted magnetic resonance imaging
    Sasaki, Makoto
    Shibata, Eri
    Ohtsuka, Kotaro
    Endoh, Jin
    Kudo, Kohsuke
    Narumi, Shinsuke
    Sakai, Akio
    [J]. NEURORADIOLOGY, 2010, 52 (02) : 83 - 89
  • [6] Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus
    Shibata, Eri
    Sasaki, Makoto
    Tohyama, Koujiro
    Otsuka, Kotaro
    Endoh, Jin
    Terayama, Yasuo
    Sakai, Akio
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 64 (05) : 401 - 406
  • [7] Striatal dopamine release in schizophrenia comorbid with substance dependence
    Thompson, J. L.
    Urban, N.
    Slifstein, M.
    Xu, X.
    Kegeles, L. S.
    Girgis, R. R.
    Beckerman, Y.
    Harkavy-Friedman, J. M.
    Gil, R.
    Abi-Dargham, A.
    [J]. MOLECULAR PSYCHIATRY, 2013, 18 (08) : 909 - 915
  • [8] The Brain on Drugs: From Reward to Addiction
    Volkow, Nora D.
    Morales, Marisela
    [J]. CELL, 2015, 162 (04) : 712 - 725
  • [9] Neuromelanin Magnetic Resonance Imaging Reveals Increased Dopaminergic Neuron Activity in the Substantia Nigra of Patients with Schizophrenia
    Watanabe, Yoshiyuki
    Tanaka, Hisashi
    Tsukabe, Akio
    Kunitomi, Yuki
    Nishizawa, Mitsuo
    Hashimoto, Ryota
    Yamamori, Hidenaga
    Fujimoto, Michiko
    Fukunaga, Masaki
    Tomiyama, Noriyuki
    [J]. PLOS ONE, 2014, 9 (08):
  • [10] Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view
    Yamamoto, Ken-ichi
    Shinba, Toshikazu
    Yoshii, Mitsunobu
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2014, 68 (01) : 1 - 20